Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bellerophon Therapeutics Inc BLPH

Healthcare Biotechnology
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:BLPH)

Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease

GlobeNewswire June 5, 2023

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

GlobeNewswire May 15, 2023

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

GlobeNewswire May 11, 2023

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

GlobeNewswire March 31, 2023

Bellerophon Therapeutics Announces $5 Million Registered Direct Offering

GlobeNewswire March 6, 2023

Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease

GlobeNewswire February 9, 2023

Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

GlobeNewswire January 18, 2023

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences

GlobeNewswire January 5, 2023

Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results

GlobeNewswire November 14, 2022
View More News ››

Opinion & Analysis (GREY:BLPH)

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 ...

Streetwise Reports March 23, 2020
View More Opinion ››

Bullboard Posts (GREY:BLPH)

Update?

So I wonder if there is anything left of the company and product potential??
Red~One - November 15, 2023

BLPH...... Dead !

Say Good night ..... vols are all but gone !
Iseneschal - March 21, 2023

BLPH...... Hurry up & Die !!!!!

Zero rev
Iseneschal - March 20, 2023

BLPH....this is the end....my only friend The End

Watch out below ; )
Iseneschal - March 20, 2023

BLPH..... I call this manip.....

"Walkin the Dog" !!! Ya never know how high they will take it ; )
Iseneschal - March 20, 2023

BLPH.....Simply amazing what "The Pros" can manip

This will implode......maybe ; ) Now trading at $7.20 JMHO
Iseneschal - March 20, 2023
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. is a technology-based company. The Company is focused on integrating emerging technologies. The Company ...
View More »